Neovasc Inc (US) (NVCN) Getting Somewhat Favorable Press Coverage, Study Shows

News coverage about Neovasc Inc (US) (NASDAQ:NVCN) (TSE:NVC) has trended somewhat positive recently, according to Accern. Accern rates the sentiment of media coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Neovasc Inc (US) earned a news impact score of 0.16 on Accern’s scale. Accern also gave news coverage about the medical equipment provider an impact score of 46.3007843067043 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

These are some of the news articles that may have effected Accern Sentiment’s scoring:

A number of equities research analysts have recently weighed in on the stock. ValuEngine downgraded shares of Neovasc Inc (US) from a “sell” rating to a “strong sell” rating in a research report on Friday, December 1st. Zacks Investment Research downgraded shares of Neovasc Inc (US) from a “buy” rating to a “hold” rating in a research report on Wednesday, October 18th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company. Neovasc Inc (US) has an average rating of “Hold” and a consensus price target of $5.19.

Shares of Neovasc Inc (NASDAQ:NVCN) traded up $0.02 on Monday, reaching $0.63. 405,100 shares of the company’s stock traded hands, compared to its average volume of 518,884. Neovasc Inc has a 1-year low of $0.54 and a 1-year high of $2.14. The firm has a market capitalization of $47.83, a P/E ratio of 2.63 and a beta of -0.07.

WARNING: “Neovasc Inc (US) (NVCN) Getting Somewhat Favorable Press Coverage, Study Shows” was posted by Week Herald and is owned by of Week Herald. If you are accessing this article on another domain, it was illegally copied and republished in violation of international trademark & copyright law. The legal version of this article can be accessed at

Neovasc Inc (US) Company Profile

Neovasc Inc (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company’s segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products.

Insider Buying and Selling by Quarter for Neovasc Inc (US) (NASDAQ:NVCN)

Receive News & Ratings for Neovasc Inc (US) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neovasc Inc (US) and related companies with's FREE daily email newsletter.

Leave a Reply